Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: past medical history: 1. hypertension. 2. hypercholesterolemia. 3. chondrocalcinosis. 4. carpal tunnel syndrome. 5. gerd. admission medications: 1. atenolol 25. 2. crestor 10 q.d. 3. uniretic 15/25. allergies: the patient has no known drug allergies. social history: the patient denied tobacco. the patient denied alcohol or other drug use. physical examination: vital signs: on admission, the patient was afebrile, blood pressure 146/88, pulse 71, respirations 18. general: the patient was a well appearing female in no acute distress. cardiac: regular rate and rhythm, normal s1, s2. no murmurs were appreciated. lungs: clear to auscultation bilaterally. abdomen: soft, nontender, nondistended, good bowel sounds. extremities: there was no edema in the extremities. the dorsalis pedis pulses were 2+ bilaterally. laboratory and radiologic data: on admission, white count 10.8, hematocrit 38.2, platelets 324,000. hospital course: 1. coronary artery disease: the patient was taken to cardiac catheterization where she was found to have two vessel disease. the proximal lad was found to have a 90% lesion with a septal branch with a 95% stenosis and a diagonal branch with 99% stenosis. the patient had twin lad stents to the lad diagonal and lad septal branches with taxus stents. this restored flow appropriately. the patient also had proximal rca lesion of 80% and a mid rca lesion of 80-90% which were not intervened upon. the patient was given an aspirin and plavix and in addition started on a beta , ace inhibitor, and these were titrated up as her blood pressure tolerated. given the fact that the patient had issues with muscle cramping with atorvastatin in the past, she was started on pravastatin which should give less of these side effects. the patient will follow-up with cardiology in one months time for further management of her coronary artery disease and further evaluation of her remaining rca lesions. 2. pump: the patient had an echocardiogram to assess her lv function. she was found to have an ejection fraction of 30-35% as well as an akinetic apex and apical mid and septal akinesis. given the fact that the patient had significant apical akinesis, she was started on heparin with a transition to coumadin for anticoagulation for stroke prevention in the setting of apical akinesis. on discharge, the patient was given lovenox injections which should be continued until the patient reaches a therapeutic dose of coumadin. 3. rhythm: the patient was monitored on telemetry throughout her hospitalization with no significant events. the patient had an ep evaluation and will be followed-up by dr. . in-house, the patient had a signal-averaged ekg. she will follow-up with dr. with an echocardiogram on in a meeting to discuss risk stratification for sudden cardiac death and possible icd placement. 4. neurology: the patient complained of left lower extremity weakness with ambulation two days after her cardiac catheterization. the patient had no evidence for weakness on examination with good proximal and distal strength in the lower extremities as well as intact sensation. the patient worked with physical therapy and was able to ambulate without difficulty. she was also able to ascend stairs without difficulty. the patient was already on an aspirin and plavix should this represent a small stroke. however, there was no evidence for neurologic deficit on examination and this will be followed-up by her primary care physician. 5. hematology: the patient was discharged on coumadin for apical akinesis and stroke risk. this will be further monitored by her primary care physician, . , who will adjust her coumadin dose. condition on discharge: stable. discharge status: to home. discharge diagnosis: st elevation myocardial infarction, status post left anterior descending artery stent. discharge medications: 1. aspirin 325 q.d. 2. lisinopril 5 q.d. 3. toprol xl 100 q.d. 4. coumadin 5 q.d. 5. plavix 75 q.d. 6. lovenox 60 mg b.i.d. until therapeutic on coumadin. 7. pravastatin 80 q.d. follow-up plans: the patient will follow-up with her primary care physician in the week following discharge for further monitoring of her inr and adjustment of her coumadin dose. the patient will also follow-up with electrophysiology with dr. on . in addition to this, the patient will follow-up with cardiology, dr. , and dr. , on for further monitoring. , m.d. dictated by: medquist36 procedure: combined right and left heart cardiac catheterization coronary arteriography using two catheters injection or infusion of platelet inhibitor insertion of drug-eluting coronary artery stent(s) diagnoses: anemia, unspecified coronary atherosclerosis of native coronary artery pure hypercholesterolemia unspecified essential hypertension acute myocardial infarction of other anterior wall, initial episode of care 

Answer: The patient is high likely exposed to